Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Short term Debt (2016 - 2025)

Sanofi's Short term Debt history spans 17 years, with the latest figure at $5.1 billion for Q4 2025.

  • On a quarterly basis, Short term Debt rose 12.37% to $5.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $5.1 billion, a 12.37% increase, with the full-year FY2025 number at $5.1 billion, up 12.37% from a year prior.
  • Short term Debt hit $5.1 billion in Q4 2025 for Sanofi, down from $8.3 billion in the prior quarter.
  • Over the last five years, Short term Debt for SNY hit a ceiling of $9.9 billion in Q2 2024 and a floor of $2.2 billion in Q4 2023.
  • Historically, Short term Debt has averaged $4.9 billion across 5 years, with a median of $4.4 billion in 2024.
  • Biggest five-year swings in Short term Debt: crashed 48.33% in 2023 and later surged 104.41% in 2024.
  • Tracing SNY's Short term Debt over 5 years: stood at $3.6 billion in 2021, then grew by 16.95% to $4.3 billion in 2022, then plummeted by 48.33% to $2.2 billion in 2023, then skyrocketed by 104.41% to $4.5 billion in 2024, then increased by 12.37% to $5.1 billion in 2025.
  • Business Quant data shows Short term Debt for SNY at $5.1 billion in Q4 2025, $8.3 billion in Q2 2025, and $4.5 billion in Q4 2024.